Ralf Lotz

USPTO Granted Patents = 16 (Patent Applications = 10)

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 4.9

ph-index = 8

Forward Citations = 325(Granted Patents)

Company Filing History:

11 out of 1,536

Boehringer Ingelheim International Gmbh

patents

4 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

1 out of 15

Sprout Pharmaceuticals, Inc.

patents

Years Active: 2008-2017

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9556175 - 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and thier use as pharmaceutical compositions (2017-01-31),

2. 9321791 - 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions (2016-04-26),

3. 8933079 - Pyridone and pyridazinone derivatives as anti-obesity agents (2015-01-13),

4. 8772298 - Spirocyclic heterocycles medicaments containing said compounds, use thereof and method for their production (2014-07-08),

5. 8722682 - Sulfated benzimidazolone derivatives having mixed serotonin receptor affinity (2014-05-13),

6. 8648191 - Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them (2014-02-11),

7. 8497369 - Spirocyclic heterocycles medicaments containing said compounds, use thereof and method for their production (2013-07-30),

8. 8178541 - 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions (2012-05-15),

9. 8119648 - 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions (2012-02-21),

10. 8067590 - Pyridone derivates with MCH antagonistic activity and medicaments comprising these compounds (2011-11-29),

11. 7998949 - Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof (2011-08-16),

12. 7838529 - Xanthine derivates, their preparation and their use in pharmaceutical compositions (2010-11-23),

13. 7696212 - Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions (2010-04-13),

14. 7592358 - Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds (2009-09-22),

15. 7524862 - Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds (2009-04-28),

Title: Ralf Lotz: Pioneering Inventor Shaping the Future of Technology

Introduction: Ralf Lotz, a visionary inventor hailing from Schemmerhofen, DE, is a trailblazer in the field of technology, known for his passion for innovation and relentless drive to push boundaries. His work continues to inspire future inventors worldwide to think boldly and create impactful solutions.

Latest Patents: With an impressive portfolio of 16 patents, Ralf Lotz's latest groundbreaking inventions include 8-[3-amino-piperidin-1-yl]-xanthines. These patented substances, with valuable pharmacological properties, have shown significant inhibiting effects on the enzyme dipeptidylpeptidase-IV (DPP-IV), opening new possibilities in pharmaceutical compositions.

Career Highlights: Ralf Lotz has made significant contributions to companies like Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. Through his innovative work, he has played a pivotal role in advancing technological solutions that have a positive impact on society.

Collaborations: Throughout his career, Ralf Lotz has collaborated with esteemed individuals in the field of technology. Notable coworkers include Frank Himmelsbach and Elke Langkopf, who have contributed to the success of his inventive projects through their expertise and dedication.

Conclusion: Ralf Lotz's relentless pursuit of innovation and his pioneering spirit have cemented his position as a visionary inventor shaping the future of technology. His inventions not only push boundaries but also inspire a new generation of inventors to dream big and create solutions that drive positive change in the world.

This text is generated by artificial intelligence and may not be accurate.